RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+12.07%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.23B
AUM Growth
+$1.23B
(+18%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
8.59%
Top 10 Holdings %
Top 10 Hldgs %
30.7%
Holding
101
New
8
Increased
39
Reduced
39
Closed
6
Top Buys
| 1 |
Inspire Medical Systems
INSP
|
$22.2M |
| 2 |
Exact Sciences
EXAS
|
$21.8M |
| 3 |
Medtronic
MDT
|
$14.4M |
| 4 |
Novo Nordisk
NVO
|
$11.9M |
| 5 |
CVS Health
CVS
|
$11.6M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$19.1M |
| 2 |
Elevance Health
ELV
|
$18.4M |
| 3 |
Oscar Health
OSCR
|
$11.4M |
| 4 |
Cigna
CI
|
$11.3M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$9.67M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Esperion Therapeutics
ESPR
$490M
| $3.26M | 0.26% |
1,975,000
| – | – |
|
77
Relay Therapeutics
RLAY
$709M
| $3.26M | 0.26% |
460,000
+230,000
| +100% | +$1.63M |
|
78
Kura Oncology
KURA
$732M
| $3.25M | 0.26% |
166,526
| – | – |
|
79
Madrigal Pharmaceuticals
MDGL
$9.7B
| $3.25M | 0.26% |
15,300
-11,200
| -42% | -$2.38M |
|
80
Arvinas
ARVN
$580M
| $3.21M | 0.26% |
130,500
-99,500
| -43% | -$2.45M |
|
81
Krystal Biotech
KRYS
$4.35B
| $3.09M | 0.25% |
17,000
-2,000
| -11% | -$364K |
|
|
IGMS
82
DELISTED
IGM Biosciences
IGMS
| $3.07M | 0.25% |
185,459
-9,541
| -5% | -$158K |
|
83
Bruker
BRKR
$4.45B
| $3.06M | 0.25% |
44,315
+38,315
| +639% | +$2.65M |
|
84
Arcellx
ACLX
$3.95B
| $2.67M | 0.22% |
+32,000
| New | +$2.67M |
|
85
Medpace
MEDP
$13.5B
| $2.5M | 0.2% |
7,500
+5,000
| +200% | +$1.67M |
|
86
Universal Health Services
UHS
$11.6B
| $1.83M | 0.15% |
+8,000
| New | +$1.83M |
|
87
Immunocore
IMCR
$1.78B
| $1.81M | 0.15% |
58,278
| – | – |
|
88
Privia Health
PRVA
$2.84B
| $1.73M | 0.14% |
95,189
-18,811
| -17% | -$343K |
|
89
Bio-Techne
TECH
$8.3B
| $1.6M | 0.13% |
20,000
| – | – |
|
90
Repligen
RGEN
$6.54B
| $1.49M | 0.12% |
10,000
| – | – |
|
91
Xenon Pharmaceuticals
XENE
$2.99B
| $1.38M | 0.11% |
35,000
| – | – |
|
92
Pliant Therapeutics
PLRX
$105M
| $1.35M | 0.11% |
120,250
| – | – |
|
93
Avantor
AVTR
$8.74B
| $1.14M | 0.09% |
44,000
-16,000
| -27% | -$414K |
|
94
Amgen
AMGN
$153B
| $967K | 0.08% |
3,000
-1,250
| -29% | -$403K |
|
95
INmune Bio
INMB
$52.4M
| $961K | 0.08% |
178,284
| – | – |
|
96
Edwards Lifesciences
EW
$47.7B
| – | – |
-97,500
| Closed | -$9.01M |
|
97
Penumbra
PEN
$10.5B
| – | – |
-23,000
| Closed | -$4.14M |
|
98
STAAR Surgical
STAA
$1.35B
| – | – |
-65,000
| Closed | -$3.09M |
|
|
NARI
99
DELISTED
Inari Medical, Inc. Common Stock
NARI
| – | – |
-20,000
| Closed | -$963K |
|
|
RVNC
100
DELISTED
Revance Therapeutics, Inc.
RVNC
| – | – |
-701,707
| Closed | -$1.8M |
|